Second hematological malignancies during arsenic trioxide therapy of B-cell lymphomas

Leuk Res. 2009 Jan;33(1):191-3. doi: 10.1016/j.leukres.2008.04.010. Epub 2008 May 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Arsenic Trioxide
  • Arsenicals / adverse effects
  • Arsenicals / therapeutic use*
  • Female
  • Hematologic Neoplasms / chemically induced*
  • Humans
  • Lymphoma, B-Cell / drug therapy*
  • Male
  • Neoplasms, Second Primary / chemically induced*
  • Oxides / adverse effects
  • Oxides / therapeutic use*

Substances

  • Arsenicals
  • Oxides
  • Arsenic Trioxide